https://www.selleckchem.com/pr....oducts/pqr309-bimira
BACKGROUND There are no sufficient data available on the use of febuxostat in patients undergoing dialysis. AIM We investigated the efficacy and tolerability of febuxostat in gout patients on dialysis. METHODS We retrospectively reviewed clinical and laboratory data available from a referral center from January 2012 to December 2018. We included gout patients who initiated febuxostat during dialysis. Data regarding serum uric acid levels before and after the febuxostat treatment and clinical information such as gout attack af
Like
Comment
Share
